Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury

Xenotransplantation

Volumn 3, Issue 1 PART 2, 1996, Pages 54-62

  Dalmasso, Agustin P ^a,b   He, Tao ^a   Benson, Barbara A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Complement; Endothelial cells; Natural antibodies; Xenoreactivity; Xenotransplantation

Indexed keywords

EID: 0002164801     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00119.x     Document Type: Article

References (26)

1. DALMASSO AP, VERCELLOTTI GM, FISCHEL RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992:140:1157.
2. ROSE AG, COOPER DKC, HUMAN PA, REICHENSPURNER H, REICHART B. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991:10:223.
3. PLATT JL, VERCELLOTTI GM, DALMASSO AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990:11:450.
4. LEVENTHAL JR, DALMASSO AP, CROMWELL JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993:55:857.
5. LEVENTHAL JR, MATAS AJ, SUN LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993:56:1.
6. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994:58:1059.
7. VANHOVE B, DE MARTIN R, LIPP J, BACH FH. Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cells. Xenotransplantation 1994:1:17.
8. RYAN US, MAXWELL G. Isolation, culture and subculture of endothelial cells: mechanical methods. J Tissue Cult Methods 1986:10:3.
9. NAGELKERKE JF, BARTO KP, BERKEL TJC. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem 1983:258:12221.
10. DALMASSO AP, PLATT JL. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993:56:1171.
11. BURSTEIN M, SCHOLNICK HR, MORFIN R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970:11:583.
12. LEVENTHAL JR, RANJIT J, FRYER JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies. Transplantation 1995:59:294.
13. FORTI RL, SCHUFFMAN SS, DAVIES HA, MITCHELL WM. Objective antiviral assay of the interferons by computer assisted data collection and analysis. Methods Enzymol 1986:119:533.
14. MIYAGAWA S, HIROSE H, SHIRAKURA R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988:46:825.
15. GALILI U. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993:14:480.
16. FRYER JP, LEVENTHAL JR, DALMASSO AP, et al. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995:59:171.
17. REITER Y, CIOBOTARIU A, JONES J, MORGAN BP, FISHELSON Z. Complement membrane attack complex, perform, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. J Immunol 1995:155:2203.
18. MORGAN BP, MERI S. Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 1994:15:369.
19. VAN DEN BERG CW, MORGAN BP. Complement-inhibiting activities of human CD59 and analogues from rat, sheep and pig are not homologously restricted. J Immunol 1994:152:4095.
20. MORGAN BP. Cellular responses to the membrane attack complex. In: Whaley K, Loos M, Weiler J, eds. Immunology and Medicine. Kluwer Academic Publishers, Norwell, MA, USA, 1993, p. 325.
21. ALEXANDRE GPJ, LATINNE D, CARLIER M, et al. ABO-incompatibility and organ transplantation. Transplant Rev 1991:5:230.
22. SLAPAK M, DIGARD N, AHMED M, SHELL T, THOMPSON F. Renal transplantation across the ABO barrier: a 9-year experience. Transplant Proc 1990:22:1425.
23. FISCHEL RJ, MATAS AJ, PERRY E, et al. Plasma exchange, organ perfusion, and immunosuppression reduce "natural" antibody levels as measured by binding to xenogeneic endothelial cells and prolong discordant xenograft survival. Transplant Proc 1992:24:574.
24. HASAN R, VAN DEN BOGAERDE J, FORTY J, et al. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. Transplant Proc 1992:24:531.
25. BACH FH, TURMAN MA, VERCELLOTTI GM, PLATT JL, DALMASSO AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991:23:205.
26. YUZAWA Y, BRETT J, FUKATSU A, et al. Interaction of antibody with Forssman antigen in guinea pigs: A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol 1995:146:1260.